title: Stereotactic body radiotherapy: an attractive treatment modality for recurrent head and neck carcinoma. (Regarding Lartigau et al.: Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer).
authors.affiliation: Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: jon.cacicedofernandezbobadilla@osakidetza.net.
authors.forename: Jon
authors.initials: J
authors.lastname: Cacicedo
authors.affiliation: Cruces University Hospital, Radiation Oncology Department, c/Plaza de Cruces s/n, 48903 Barakaldo, Vizcaya (Basque Country), Spain. Electronic address: Pedro.bilbaozulaica@osakidetza.net.
authors.forename: Pedro
authors.initials: P
authors.lastname: Bilbao
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000628:therapy*; D016634:Radiosurgery
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors